Search research articles
Contact Us
Filters
Showing results (31-40 of 79) with videos related to
Page
of 8
Sort By:
Archives of Biochemistry and Biophysics
|
November 1, 2003
Sphingomyelin in the suppression of colon tumors: prevention versus intervention
Lori A Lemonnier, Dirck L Dillehay, Michael J Vespremi, et al.
Medical Oncology (Northwood, London, England)
|
May 26, 2009
Utility of DNA postreplication repair protein Rad6B in neoadjuvant chemotherapy response
Malathy P V Shekhar, Laura A Biernat, Nat Pernick, et al.
Breast Cancer Research and Treatment
|
November 16, 2011
A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer
Elaina M Gartner, Paula Silverman, Michael Simon, et al.
Journal of Hematology & Oncology
|
September 20, 2012
HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (cis-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas
Angela M Sosin, Angelika M Burger, Aisha Siddiqi, et al.
The Breast Journal
|
February 27, 2007
Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population
Maria J Worsham, Judith Abrams, Usha Raju, et al.
Lung Cancer (Auckland, N.Z.)
|
October 2, 2019
A retrospective study evaluating the pretreatment tumor volume (PTV) in non-small cell lung cancer (NSCLC) as a predictor of response to program death-1 (PD-1) inhibitors
Misako Nagasaka, Nadine Abdallah, Marcus Crosby, et al.
Journal of Cancer Epidemiology
|
May 7, 2010
Chromosome 5p Region SNPs Are Associated with Risk of NSCLC among Women
Alison L Van Dyke, Michele L Cote, Angela S Wenzlaff, et al.
The Journal of Biological Chemistry
|
May 9, 2003
Mutation of Leu-536 in human estrogen receptor-alpha alters the coupling between ligand binding, transcription activation, and receptor conformation
Changqing Zhao, Akiko Koide, Judith Abrams, et al.
American Journal of Preventive Medicine
|
August 23, 2008
Challenges for multilevel health disparities research in a transdisciplinary environment
John H Holmes, Amy Lehman, Erinn Hade, et al.
Cancer Research
|
November 25, 2010
A novel signaling axis of matriptase/PDGF-D/ß-PDGFR in human prostate cancer
Carolyn V Ustach, Wei Huang, M Katie Conley-LaComb, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 79) with videos related to
Sort By:
Page
of 8
Archives of Biochemistry and Biophysics
|
November 1, 2003
Sphingomyelin in the suppression of colon tumors: prevention versus intervention
Lori A Lemonnier, Dirck L Dillehay, Michael J Vespremi, et al.
Medical Oncology (Northwood, London, England)
|
May 26, 2009
Utility of DNA postreplication repair protein Rad6B in neoadjuvant chemotherapy response
Malathy P V Shekhar, Laura A Biernat, Nat Pernick, et al.
Breast Cancer Research and Treatment
|
November 16, 2011
A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer
Elaina M Gartner, Paula Silverman, Michael Simon, et al.
Journal of Hematology & Oncology
|
September 20, 2012
HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (cis-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas
Angela M Sosin, Angelika M Burger, Aisha Siddiqi, et al.
The Breast Journal
|
February 27, 2007
Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population
Maria J Worsham, Judith Abrams, Usha Raju, et al.
Lung Cancer (Auckland, N.Z.)
|
October 2, 2019
A retrospective study evaluating the pretreatment tumor volume (PTV) in non-small cell lung cancer (NSCLC) as a predictor of response to program death-1 (PD-1) inhibitors
Misako Nagasaka, Nadine Abdallah, Marcus Crosby, et al.
Journal of Cancer Epidemiology
|
May 7, 2010
Chromosome 5p Region SNPs Are Associated with Risk of NSCLC among Women
Alison L Van Dyke, Michele L Cote, Angela S Wenzlaff, et al.
The Journal of Biological Chemistry
|
May 9, 2003
Mutation of Leu-536 in human estrogen receptor-alpha alters the coupling between ligand binding, transcription activation, and receptor conformation
Changqing Zhao, Akiko Koide, Judith Abrams, et al.
American Journal of Preventive Medicine
|
August 23, 2008
Challenges for multilevel health disparities research in a transdisciplinary environment
John H Holmes, Amy Lehman, Erinn Hade, et al.
Cancer Research
|
November 25, 2010
A novel signaling axis of matriptase/PDGF-D/ß-PDGFR in human prostate cancer
Carolyn V Ustach, Wei Huang, M Katie Conley-LaComb, et al.
Page
of 8